Veru (VERU) Competitors $0.49 +0.01 (+1.82%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.48 -0.01 (-1.72%) As of 08/1/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERU vs. NATR, MED, EL, IPAR, PBH, HLF, USNA, NUS, SNWV, and ACBShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Nature's Sunshine Products (NATR), Medifast (MED), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Sanuwave Health (SNWV), and Aurora Cannabis (ACB). Veru vs. Its Competitors Nature's Sunshine Products Medifast Estee Lauder Companies Interparfums Prestige Consumer Healthcare Herbalife USANA Health Sciences Nu Skin Enterprises Sanuwave Health Aurora Cannabis Nature's Sunshine Products (NASDAQ:NATR) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Do insiders and institutionals believe in NATR or VERU? 79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 4.7% of Nature's Sunshine Products shares are owned by insiders. Comparatively, 15.2% of Veru shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is NATR or VERU more profitable? Nature's Sunshine Products has a net margin of 3.06% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 10.19% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets Nature's Sunshine Products3.06% 10.19% 6.76% Veru N/A -128.51%-76.51% Do analysts prefer NATR or VERU? Nature's Sunshine Products currently has a consensus target price of $19.67, indicating a potential upside of 24.47%. Veru has a consensus target price of $4.00, indicating a potential upside of 710.54%. Given Veru's higher possible upside, analysts clearly believe Veru is more favorable than Nature's Sunshine Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nature's Sunshine Products 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Veru 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, NATR or VERU? Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNature's Sunshine Products$454.36M0.64$7.70M$0.5329.81Veru$16.89M4.28-$37.80M-$0.24-2.06 Which has more volatility and risk, NATR or VERU? Nature's Sunshine Products has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Veru has a beta of -0.71, suggesting that its stock price is 171% less volatile than the S&P 500. Does the media favor NATR or VERU? In the previous week, Nature's Sunshine Products had 9 more articles in the media than Veru. MarketBeat recorded 11 mentions for Nature's Sunshine Products and 2 mentions for Veru. Nature's Sunshine Products' average media sentiment score of 1.27 beat Veru's score of 0.62 indicating that Nature's Sunshine Products is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nature's Sunshine Products 3 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veru 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNature's Sunshine Products beats Veru on 12 of the 15 factors compared between the two stocks. Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.05M$10.40B$5.48B$9.51BDividend YieldN/A1.99%4.73%4.09%P/E Ratio-2.0618.4228.6723.80Price / Sales4.2829.01373.9066.58Price / CashN/A22.3135.4557.96Price / Book2.243.478.275.55Net Income-$37.80M$234.77M$3.24B$259.03M7 Day Performance-12.00%-4.82%-3.69%-4.59%1 Month Performance-15.44%1.80%4.33%4.46%1 Year Performance-41.21%-12.51%25.95%18.03% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru1.835 of 5 stars$0.49+1.8%$4.00+710.5%-44.5%$71.05M$16.89M-2.06230News CoverageUpcoming EarningsShort Interest ↑NATRNature's Sunshine Products2.5738 of 5 stars$14.73+0.1%$18.33+24.5%-3.8%$271.96M$456.62M27.79850News CoveragePositive NewsEarnings ReportAnalyst ForecastGap UpMEDMedifast3.5239 of 5 stars$14.58-2.1%$16.50+13.2%-36.6%$160.23M$602.46M-22.43870News CoverageUpcoming EarningsELEstee Lauder Companies4.0875 of 5 stars$92.58+2.4%$84.50-8.7%-6.3%$33.31B$14.79B-38.2662,000Positive NewsGap DownIPARInterparfums4.3674 of 5 stars$125.09+3.3%$162.00+29.5%-13.9%$4.02B$1.45B24.34530News CoverageUpcoming EarningsAnalyst RevisionPBHPrestige Consumer Healthcare4.5483 of 5 stars$76.34-0.7%$93.33+22.3%+4.5%$3.77B$1.14B17.79540Positive NewsUpcoming EarningsHLFHerbalife4.4211 of 5 stars$9.75flat$11.50+17.9%-18.3%$993.04M$4.99B3.568,600Upcoming EarningsAnalyst UpgradeUSNAUSANA Health Sciences4.1353 of 5 stars$31.47-1.5%$36.00+14.4%-33.4%$586.03M$854.50M17.491,700Insider TradeShort Interest ↑NUSNu Skin Enterprises3.4381 of 5 stars$8.88+1.5%$6.88-22.6%-25.2%$438.76M$1.73B-11.103,100News CoverageUpcoming EarningsSNWVSanuwave Health2.2594 of 5 stars$35.75-5.6%N/AN/A$306.38M$32.63M-7.8540News CoverageAnalyst ForecastAnalyst RevisionACBAurora Cannabis0.3762 of 5 stars$4.78-1.2%N/A-26.0%$268.86M$343.29M43.451,130Upcoming Earnings Related Companies and Tools Related Companies NATR Alternatives MED Alternatives EL Alternatives IPAR Alternatives PBH Alternatives HLF Alternatives USNA Alternatives NUS Alternatives SNWV Alternatives ACB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERU) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
